Publications:

A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma.

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology

Jonasch, E E; Hasanov, E E; Corn, P G PG; Moss, T T; Shaw, K R KR; Stovall, S S; Marcott, V V; Gan, B B; Bird, S S; Wang, X X; Do, K A KA; Altamirano, P F PF; Zurita, A J AJ; Doyle, L A LA; Lara, P N PN; Tannir, N M NM

Publication Date: 2017-04-01

Variant appearance in text: ATM: S978F

PubMed Link: 28049139

Variant Present in the following documents:

• Main text

View BVdb publication page